-
-
Roche's Q1 2025 Financial report
Financial statements
Roche Q1 2025 financial results show 6% revenue growth, driven by strong demand for innovative drugs and diagnostics. China leads international growth, while the company makes strategic investments in the US and global R&D.
-
Merck's Q1 2025 Financial report
Financial statements
Merck's Q1 2025 earnings show a 2% decline in revenue, with strong growth in KEYTRUDA and animal health products. The company faces short-term challenges but continues to drive innovation in its R&D pipeline.
-
Sanofi's Q1 2025 Financial report
Sanofi
Sanofi's Q1 2025 report shows a 9.7% sales growth, driven by Dupixent and innovative drugs. The company confirms full-year guidance with strong performance in immunology, rare diseases, and vaccines.
-
BMS's Q1 2025 Financial report
Market Trend
Bristol Myers Squibb Q1 2025 earnings: revenue down 6% YoY, but strong product performance drives EPS growth. Full-year guidance raised. Highlights include Opdivo, Reblozyl, and Breyanzi.
-
AkzoNobel Q1 2025 Earnings Report
Market Trend
AkzoNobel reports €2.613B Q1 2025 revenue with strong marine and protective coatings growth. CEO outlines resilience amid tariffs and economic uncertainty. Adjusted EBITDA margin at 13.7%.
-
-
-
-
北碚区|
台江县|
德格县|
三原县|
和平县|
安仁县|
宿迁市|
葵青区|
临邑县|
彰化县|
揭阳市|
河间市|
彭州市|
勃利县|
亚东县|
芜湖县|
福海县|
宿迁市|
施秉县|
买车|
商水县|
麻阳|
安徽省|
贡觉县|
寿阳县|
金门县|
双流县|
额敏县|
松江区|
新津县|
宜兰县|
桦川县|
阜南县|
台山市|
亚东县|
彰化市|
奈曼旗|
武夷山市|
盐亭县|
府谷县|
阿合奇县|